Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients

Clinical trial NCT02442206 · COMPLETED

Trial details

NCT number: NCT02442206
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease, COPD

Start date: 2015-05-18
Primary completion: 2017-04-20
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.